Skip to main content
. 2001 Mar;123(3):465–471. doi: 10.1046/j.1365-2249.2001.01478.x

Fig. 2.

Fig. 2

ELISA evaluation of the reactivity of 20 sera from Chagas' disease (▪), 10 sera from leishmaniasis (Inline graphic), 5 sera from tuberculosis (□), 5 sera from malaria (▪) patients and 10 sera from healthy donors (Inline graphic) were assayed against the recombinant KMP11 protein. n, number of sera used in each group. The patient's sera were assayed at 1 : 800 dilution and the healthy donors sera were used at 1 : 200 dilution.